Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACOR - Acorda Therapeutics GAAP EPS of $0.57 revenue of $31.47M

ACOR - Acorda Therapeutics GAAP EPS of $0.57 revenue of $31.47M

Acorda Therapeutics Inc.

2023-03-09 07:01:47 ET

  • Acorda Therapeutics press release ( NASDAQ: ACOR ): Q4 GAAP EPS of $0.57.
  • Revenue of $31.47M (-12.8% Y/Y).
  • For the full year 2023, the Company is targeting INBRIJA U.S. net revenue to be $38 - $42 million.
  • The Company is targeting adjusted OPEX to be $93 - $103 million and ending cash balance to be $43 - $47 million.

For further details see:

Acorda Therapeutics GAAP EPS of $0.57, revenue of $31.47M
Stock Information
Company Name: Acorda Therapeutics Inc.
Stock Symbol: ACOR
Market: NASDAQ
Website: acorda.com
Menu
ACOR ACOR Quote ACOR Short ACOR News ACOR Articles ACOR Message Board
Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...